“…Myopic maculopathy is the main cause of vision loss among highly myopic patients, and the leading aetiology of subfoveal choroidal neovascularization (CNV) among patients younger than 50 years of age. 1 Different therapeutic approaches have been tried to treat myopic CNV, including argon laser photocoagulation, 2,3 surgical removal, and macular translocation, 4,5 and, more recently, photodynamic therapy (PDT) with verteporfin. [6][7][8] Visual deterioration secondary to retinal pigment epithelium (RPE) and choriocapillaris atrophy, and the frequent need to repeat PDT sessions have lead to the association of intravitreal triamcinolone and PDT.…”